EASYTRAK 3
Report
- Report Number
- 2124215-2011-00798
- Event Type
- Malfunction
- Date Received
- January 18, 2011
- Date of Event
- December 27, 2010
- Report Date
- February 4, 2011
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- OJX
- PMA / PMN Number
- P010012
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION NOTED THE COMPLETE LEAD WAS RETURNED. ELECTROSURGICAL CAUTERY DAMAGE WAS NOTED IN SEVERAL PLACES ON THE LEAD. DRIED BLOOD/BODY FLUID WAS NOTED IN THE LEAD LUMEN. THE LEAD CONDUCTORS TESTED ELECTRICALLY CONTINUOUS. THE REPORTED LEAD DAMAGE WAS NOT CONFIRMED IN ANALYSIS.
AS OF TODAY, THE EXPLANTED PRODUCTS HAVE NOT BEEN RETURNED FOR ANALYSIS. IF THE PRODUCTS ARE RETURNED OR IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.
THE LEAD WAS RETURNED FOR ANALYSIS.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING THE DEVICE REPLACEMENT PROCEDURE, THE RIGHT ATRIAL PORT SET SCREWS AND THE RIGHT VENTRICULAR PACE/SENSE PORT SET SCREWS ON THIS DEVICE HEADER WERE STUCK AND COULD NOT BE RETRACTED. A BIDIRECTIONAL TORQUE WRENCH TIP BROKE OFF IN THE RIGHT VENTRICULAR PACE/SENSE HEX SLOT AFTER TRYING FOUR DIFFERENT WRENCHES. MINERAL OIL WAS ATTEMPTED AND A STERNUM CLIPPER WAS USED TO CUT THE DEVICE HEADER IN AN ATTEMPT TO FREE THE TWO LEADS. THE LEADS REMAINED STUCK IN THE DEVICE HEADER. SUBSEQUENTLY ALL OF THE LEADS WERE CUT AND ABANDONED TO REMOVE THE DEVICE. THE PATIENT WAS THEN TRANSFERRED TO ANOTHER HOSPITAL IN A STABLE CONDITION. ONE DAY LATER, THE LEADS WERE EXTRACTED AND A NEW SYSTEM WAS IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED DUE TO THE EXPLANT AND REPLACEMENT PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | EASYTRAK 3 | IMPLANTABLE LEAD | OJX | CPI - DEL CARIBE | 4549 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | (B)(4)| (B)(4)| (B)(4)| (B)(4) |